Interactive and individual effects of dietary non-digestible carbohydrates and oils on DNA damage, SCFA and bacteria in the large bowel of rats.
Dietary non-digestible carbohydrates (NDC) play an important role in large-bowel health and one form of NDC, resistant starch (RS), can promote low levels of DNA damage and other markers of colonic health. The objective of the present study was to determine whether the ability of dietary RS or other NDC to influence colonic health, particularly DNA damage, is dependent on the type of dietary oil. We compared the effects of diets containing 10 % of NDC from cellulose, wheat bran, high-amylose maize starch (HAS, a rich source of RS type 2) or a retrograded HAS (RHAS, a rich source of RS type 3) on DNA damage, SCFA production and bacterial changes in the large bowel of rats. Each carbohydrate source was combined with 10 % fish oil (FO) or Sunola oil (SO; rich in oleic acid). There was a significant interaction between NDC and oil treatments on single-strand DNA breaks in colonocytes isolated from the colon. The damage in rats consuming RHAS was greater for FO consumption than for SO consumption. There was a significant interaction between NDC and oils on caecum weights and treatment effects of NDC and oils were observed for the weights and lengths of other gut tissues. Significant differences were found in colonic SCFA pools and caecal numbers of lactobacilli, bifidobacteria, Escherichia coli and Bacteroides fragilis with the various NDC and oil treatments. The present results demonstrate that the effects of NDC and oils, particularly on colonic DNA damage, can depend on how they are combined within the diet.
Conlon
Michael A
MA
CSIRO Human Nutrition, PO Box 10041, Adelaide BC, SA 5000, Australia. michael.conlon@csiro.au
Bird
Anthony R
AR
D000818:Animals; D001419:Bacteria / Q000302:isolation & purification; D001835:Body Weight / Q000187:drug effects; D002432:Cecum / Q000187:drug effects / Q000382:microbiology; D004249:DNA Damage; D004032:Diet; D004040:Dietary Carbohydrates / Q000494:pharmacology*; D004042:Dietary Fats, Unsaturated / Q000494:pharmacology*; D004347:Drug Interactions; D005232:Fatty Acids, Volatile / Q000096:biosynthesis*; D005395:Fish Oils / Q000494:pharmacology; D007420:Intestine, Large / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D019301:Oleic Acid / Q000494:pharmacology; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley
D004040:Dietary Carbohydrates; D004042:Dietary Fats, Unsaturated; D005232:Fatty Acids, Volatile; D005395:Fish Oils; D019301:Oleic Acid